These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
500 related items for PubMed ID: 36746361
1. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [18F]LW223 as a TSPO-targeted PET radioligand. Tan Z, Haider A, Zhang S, Chen J, Wei J, Liao K, Li G, Wei H, Dong C, Ran W, Li Y, Li Y, Rong J, Li Y, Liang SH, Xu H, Wang L. Pharmacol Res; 2023 Mar; 189():106681. PubMed ID: 36746361 [Abstract] [Full Text] [Related]
2. Quantification of Macrophage-Driven Inflammation During Myocardial Infarction with 18F-LW223, a Novel TSPO Radiotracer with Binding Independent of the rs6971 Human Polymorphism. MacAskill MG, Stadulyte A, Williams L, Morgan TEF, Sloan NL, Alcaide-Corral CJ, Walton T, Wimberley C, McKenzie CA, Spath N, Mungall W, BouHaidar R, Dweck MR, Gray GA, Newby DE, Lucatelli C, Sutherland A, Pimlott SL, Tavares AAS. J Nucl Med; 2021 Apr; 62(4):536-544. PubMed ID: 32859708 [Abstract] [Full Text] [Related]
3. Modelling [18F]LW223 PET data using simplified imaging protocols for quantification of TSPO expression in the rat heart and brain. MacAskill MG, Wimberley C, Morgan TEF, Alcaide-Corral CJ, Newby DE, Lucatelli C, Sutherland A, Pimlott SL, Tavares AAS. Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):137-145. PubMed ID: 34338808 [Abstract] [Full Text] [Related]
4. Preclinical characterization of [18F]D2-LW223: an improved metabolically stable PET tracer for imaging the translocator protein 18 kDa (TSPO) in neuroinflammatory rodent models and non-human primates. Liao K, Chen JH, Ma J, Dong CC, Bi CY, Gao YB, Jiang YF, Wang T, Wei HY, Hou L, Hu JQ, Wei JJ, Zeng CY, Li YL, Yan S, Xu H, Liang SH, Wang L. Acta Pharmacol Sin; 2024 Aug 29. PubMed ID: 39210042 [Abstract] [Full Text] [Related]
5. Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain. Feeney C, Scott G, Raffel J, Roberts S, Coello C, Jolly A, Searle G, Goldstone AP, Brooks DJ, Nicholas RS, Trigg W, Gunn RN, Sharp DJ. Eur J Nucl Med Mol Imaging; 2016 Nov 29; 43(12):2201-2210. PubMed ID: 27349244 [Abstract] [Full Text] [Related]
6. [18F]LW223 has low non-displaceable binding in murine brain, enabling high sensitivity TSPO PET imaging. Knyzeliene A, MacAskill MG, Alcaide-Corral CJ, Morgan TE, Henry MC, Lucatelli C, Pimlott SL, Sutherland A, Tavares AA. J Cereb Blood Flow Metab; 2024 Mar 29; 44(3):397-406. PubMed ID: 37795635 [Abstract] [Full Text] [Related]
7. In vivo evaluation of a novel 18F-labeled PET radioligand for translocator protein 18 kDa (TSPO) in monkey brain. Yan X, Siméon FG, Liow JS, Morse CL, Montero Santamaria JA, Jenkins M, Manly LS, Van Buskirk M, Zoghbi SS, Pike VW, Innis RB, Zanotti-Fregonara P. Eur J Nucl Med Mol Imaging; 2023 Aug 29; 50(10):2962-2970. PubMed ID: 37249618 [Abstract] [Full Text] [Related]
8. Preclinical evaluation of (S)-[18F]GE387, a novel 18-kDa translocator protein (TSPO) PET radioligand with low binding sensitivity to human polymorphism rs6971. Ramakrishnan NK, Hird M, Thompson S, Williamson DJ, Qiao L, Owen DR, Brooks AF, Scott PJH, Bacallado S, O'Brien JT, Aigbirhio FI. Eur J Nucl Med Mol Imaging; 2021 Dec 29; 49(1):125-136. PubMed ID: 34405276 [Abstract] [Full Text] [Related]
9. Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein. Fan Z, Calsolaro V, Atkinson RA, Femminella GD, Waldman A, Buckley C, Trigg W, Brooks DJ, Hinz R, Edison P. J Nucl Med; 2016 Nov 29; 57(11):1753-1759. PubMed ID: 27261523 [Abstract] [Full Text] [Related]
10. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180. Chau WF, Black AM, Clarke A, Durrant C, Gausemel I, Khan I, Mantzilas D, Oulie I, Rogstad A, Trigg W, Jones PA. Nucl Med Biol; 2015 Sep 29; 42(9):711-9. PubMed ID: 26072270 [Abstract] [Full Text] [Related]
11. Radiosynthesis and characterization of [18F]BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism. Lee SH, Denora N, Laquintana V, Mangiatordi GF, Lopedota A, Lopalco A, Cutrignelli A, Franco M, Delre P, Song IH, Kim HW, Kim SB, Park HS, Kim K, Lee SY, Youn H, Lee BC, Kim SE. Eur J Nucl Med Mol Imaging; 2021 Dec 29; 49(1):110-124. PubMed ID: 34783879 [Abstract] [Full Text] [Related]
12. In Vivo Evaluation of 6 Analogs of 11C-ER176 as Candidate 18F-Labeled Radioligands for 18-kDa Translocator Protein. Lee JH, Siméon FG, Liow JS, Morse CL, Gladding RL, Santamaria JAM, Henter ID, Zoghbi SS, Pike VW, Innis RB. J Nucl Med; 2022 Aug 29; 63(8):1252-1258. PubMed ID: 35027372 [Abstract] [Full Text] [Related]
13. [18F]CB251 PET/MR imaging probe targeting translocator protein (TSPO) independent of its Polymorphism in a Neuroinflammation Model. Kim K, Kim H, Bae SH, Lee SY, Kim YH, Na J, Lee CH, Lee MS, Ko GB, Kim KY, Lee SH, Song IH, Cheon GJ, Kang KW, Kim SE, Chung JK, Kim EE, Paek SH, Lee JS, Lee BC, Youn H. Theranostics; 2020 Aug 29; 10(20):9315-9331. PubMed ID: 32802194 [Abstract] [Full Text] [Related]
14. Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F]PBR102 and [18F]PBR111. Eberl S, Katsifis A, Peyronneau MA, Wen L, Henderson D, Loc'h C, Greguric I, Verschuer J, Pham T, Lam P, Mattner F, Mohamed A, Fulham MJ. Eur J Nucl Med Mol Imaging; 2017 Feb 29; 44(2):296-307. PubMed ID: 27699720 [Abstract] [Full Text] [Related]
15. In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients. Varrone A, Mattsson P, Forsberg A, Takano A, Nag S, Gulyás B, Borg J, Boellaard R, Al-Tawil N, Eriksdotter M, Zimmermann T, Schultze-Mosgau M, Thiele A, Hoffmann A, Lammertsma AA, Halldin C. Eur J Nucl Med Mol Imaging; 2013 Jun 29; 40(6):921-31. PubMed ID: 23436070 [Abstract] [Full Text] [Related]
16. Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of 18F-PI-2620 PET for the Assessment of Tau Deposits in the Human Brain. Bullich S, Barret O, Constantinescu C, Sandiego C, Mueller A, Berndt M, Papin C, Perrotin A, Koglin N, Kroth H, Pfeifer A, Tamagnan G, Madonia J, Seibyl JP, Marek K, De Santi S, Dinkelborg LM, Stephens AW. J Nucl Med; 2020 Jun 29; 61(6):920-927. PubMed ID: 31712324 [Abstract] [Full Text] [Related]
17. Recent developments on PET radiotracers for TSPO and their applications in neuroimaging. Zhang L, Hu K, Shao T, Hou L, Zhang S, Ye W, Josephson L, Meyer JH, Zhang MR, Vasdev N, Wang J, Xu H, Wang L, Liang SH. Acta Pharm Sin B; 2021 Feb 29; 11(2):373-393. PubMed ID: 33643818 [Abstract] [Full Text] [Related]
18. Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter. Sridharan S, Raffel J, Nandoskar A, Record C, Brooks DJ, Owen D, Sharp D, Muraro PA, Gunn R, Nicholas R. Mol Imaging Biol; 2019 Oct 29; 21(5):935-944. PubMed ID: 30796709 [Abstract] [Full Text] [Related]
19. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine. Sabri O, Becker GA, Meyer PM, Hesse S, Wilke S, Graef S, Patt M, Luthardt J, Wagenknecht G, Hoepping A, Smits R, Franke A, Sattler B, Habermann B, Neuhaus P, Fischer S, Tiepolt S, Deuther-Conrad W, Barthel H, Schönknecht P, Brust P. Neuroimage; 2015 Sep 29; 118():199-208. PubMed ID: 26037057 [Abstract] [Full Text] [Related]
20. Preclinical Evaluation and Quantification of 18F-Fluoroethyl and 18F-Fluoropropyl Analogs of SCH442416 as Radioligands for PET Imaging of the Adenosine A2A Receptor in Rat Brain. Khanapur S, van Waarde A, Dierckx RA, Elsinga PH, Koole MJ. J Nucl Med; 2017 Mar 29; 58(3):466-472. PubMed ID: 27789720 [Abstract] [Full Text] [Related] Page: [Next] [New Search]